Form D — OWP PHARMACEUTICALS, INC.
0002037010-25-000001 · filed Sep 9, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $2,405,000
- Reported amount sold
- $2,405,000
- Minimum investment
- $25,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OWP PHARMACEUTICALS, INC.
- CIK
- 2037010
- Entity
- Corporation
- Jurisdiction
- ILLINOIS
- Year incorporated
- —
- Address
- 701 WARRENVILLE ROAD
LISLE, Illinois 60532 - Phone
- 847-722-0803
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
KURT FLORIAN · DirectorLISLE, Illinois Find on LinkedIn ↗
-
MATT LITFIN · DirectorLISLE, Illinois Find on LinkedIn ↗
-
SCOTT BOYER · Executive OfficerLISLE, Illinois Find on LinkedIn ↗
-
BRUCE DUNCAN · DirectorLISLE, Illinois Find on LinkedIn ↗
-
TROY HAMMOND · DirectorLISLE, Illinois Find on LinkedIn ↗
-
STEVE BOURNE · Executive OfficerLISLE, Illinois Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗